6 Followers on Owler

DiaMedica Therapeutics

is a Minnesota-based clinical-stage biopharmaceutical company that develops novel therapies for the treatment of ischemic disease... Read more
OverviewCompetitorsFundingNews & Insights

DiaMedica Therapeutics

is a Minnesota-based clinical-stage biopharmaceutical company that develops novel therapies for the treatment of ischemic disease... Read more
DiaMedica Therapeutics President & CEO: Rick Pauls

President & CEO

Rick Pauls

CEO Approval Rating

90/100

2000

PublicIndependent CompanyNASDAQDMAC

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
5047 NAICS listing

Annual Revenue
$4.7M
Employees
20
Funding
$129.1M

News

Conference Presentation
Feb 10, 2025
Yahoo
DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Funding
Jul 01, 2024
Business Wire
DiaMedica received $11.8M in Private Placement Funding

DiaMedica Therapeutics Competitors

1Cellectar
2Vistagen
3Regulus
4Neurona
5Goldfinch Bio
Unlock 2 + competitors

Trending Companies